SITC gratefully acknowledges the following supporters of the society's 37th Annual Meeting & Pre-Conference Programs.
37th Annual Meeting
Platinum
Agenus, Inc.
Amgen
AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb
Incyte Corporation
Gold
Genmab US, Inc
Sanofi US Services, Inc.
Silver
AbbVie
Alkermes, Inc.
Janssen Pharmaceutical Research & Development, LLC
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)
Bronze
BeiGene USA, Inc.
Iovance Biotherapeutics
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
Copper
Bayer Healthcare Pharmaceuticals Inc. (Young Investigator Travel Awards)
Immatics Biotechnologies GmbH (The CheckPoints Party)
Nanobiotix
Personalis, Inc. (The CheckPoints Party)
Veranome Biosystems (Young Investigator Travel Awards)
Primer on Tumor Immunology and Cancer ImmunotherapyTM
Bronze
Genentech, a member of the Roche Group
Incyte Corporation
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)
Pfizer, Inc.
Combination Therapy: Applying Learnings from Past Successes and Failures to Future Treatments (SITC Workshop)
Silver
Bristol Myers Squibb
Incyte Corporation
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)
Bronze
Alkermes, Inc.
Genmab US, Inc.
Combination Therapy: Using Novel Approaches to Identify Novel Biomarkers, Inform Patient Selection, and Design Trials
Gold
AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb
Silver
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)
Supporters as of October 13, 2022